Kenneth D. Bahk
Directeur/Membre du Conseil chez Inflammatix, Inc.
Profil
Kenneth D.
Bahk is currently a Director at Inflammatix, Inc., a Member at the American Society for Microbiology, a Member at the American Association for Clinical Chemistry, Inc., and a Member at the Association for Molecular Pathology.
Previously, he was a Director at Viamet Pharmaceuticals, Inc., GeneWeave Biosciences, Inc., Viamet Pharmaceuticals Corp., and Aperion Biologics, Inc. He also served as the Chief Strategy Officer at Nanosphere, Inc. Dr. Bahk holds a graduate and doctorate degree from Northwestern University and an MBA from Kellogg School of Management.
Postes actifs de Kenneth D. Bahk
| Sociétés | Poste | Début |
|---|---|---|
American Association for Clinical Chemistry, Inc.
 American Association for Clinical Chemistry, Inc. Medical/Nursing ServicesHealth Services American Association for Clinical Chemistry, Inc. (AACC) is a scientific and medical professional organization that focuses on clinical laboratory science and its application to healthcare. The organization is based in Washington and was founded in 1948. AACC provides leadership in education, advocacy, and collaboration to help lab professionals adapt to change and provide vital insight and guidance for patient care. The organization offers accreditation programs, press releases, media advisories, and statements that spotlight scientific, clinical, and technological breakthroughs. AACC has a longstanding commitment to provide customers with the best possible experience every time they use the AACC website. Mark J. Golden has been the CEO of the American company since 2020. | Corporate Officer/Principal | - |
American Society for Microbiology
 American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services The American Society for Microbiology (ASM) is the oldest and largest single life science membership organization in the world. The private company is based in Washington and has subsidiaries in the United States. ASM's membership has grown from 59 scientists in 1899 to more than 39,000 members today, with more than one third located outside. The members represent 26 disciplines of microbiological specialization plus a division for microbiology educators. | Corporate Officer/Principal | - |
Association for Molecular Pathology
 Association for Molecular Pathology BiotechnologyHealth Technology The Association for Molecular Pathology develops molecular diagnostics. The American company was founded by Jeffrey Cossman. | Corporate Officer/Principal | - |
Inflammatix, Inc.
 Inflammatix, Inc. Medical SpecialtiesHealth Technology Inflammatix, Inc. operates molecular diagnostics company which develops rapid tests that read the immune system. The firm specializes in molecular diagnostics, biotechnology, computational immunology, in-vitro diagnostics, personalized medicine and bioinformatics. The company was founded by Purvesh Khatri, Jonathan Romanowsky and Timothy Sweeney and is headquartered in Burlingame, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Kenneth D. Bahk
| Sociétés | Poste | Fin |
|---|---|---|
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | - |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | - |
| APERION BIOLOGICS, INC. | Directeur/Membre du Conseil | - |
GeneWeave Biosciences, Inc.
 GeneWeave Biosciences, Inc. Medical/Nursing ServicesHealth Services GeneWeave Biosciences, Inc. developed a platform for detecting infectious diseases. It developed clinical microbiology with diagnostic solutions to aid healthcare providers in the treatment of drug-resistant bacteria. The company was founded by Jason Springs, Diego A. Rey and Leo Teixeira in 2007 and was headquartered in Los Gatos, CA. | Directeur/Membre du Conseil | - |
| NANOSPHERE, INC. | Corporate Officer/Principal | - |
Formation de Kenneth D. Bahk
| Northwestern University | Doctorate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Nanosphere, Inc.
 Nanosphere, Inc. Medical SpecialtiesHealth Technology Nanosphere, Inc. engages in the development, manufacture, and market of molecular diagnostics platform. Its platform, Verigene System, enables clinicians to identify and treat bacteria and viruses responsible for some of the most complex, costly, and deadly infectious diseases. The company was founded by Chad A. Mirkin and Robert Letsinger on December 30, 1999 and is headquartered in Northbrook, IL. | Health Technology |
Aperion Biologics, Inc.
 Aperion Biologics, Inc. Medical DistributorsDistribution Services Aperion Biologics, Inc. engages in the development and implementation of its business plans, performing research on its platform technology, conducting clinical trials on its products in both animals and humans, pursuing regulatory approvals to market its product in U.S. and international markets, and raising capital. The firm's core platform technology is an enzymatic stripping of the key carbohydrate antigens followed by a unique conversion process that both humanizes and sterilizes the tissues without affecting their biomechanical or biological properties. The company was founded by Kevin Robert Stone in October 1996 and is headquartered in San Antonio, TX. | Distribution Services |
GeneWeave Biosciences, Inc.
GeneWeave Biosciences, Inc. Medical/Nursing ServicesHealth Services GeneWeave Biosciences, Inc. developed a platform for detecting infectious diseases. It developed clinical microbiology with diagnostic solutions to aid healthcare providers in the treatment of drug-resistant bacteria. The company was founded by Jason Springs, Diego A. Rey and Leo Teixeira in 2007 and was headquartered in Los Gatos, CA. | Health Services |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Health Technology |
American Association for Clinical Chemistry, Inc.
American Association for Clinical Chemistry, Inc. Medical/Nursing ServicesHealth Services American Association for Clinical Chemistry, Inc. (AACC) is a scientific and medical professional organization that focuses on clinical laboratory science and its application to healthcare. The organization is based in Washington and was founded in 1948. AACC provides leadership in education, advocacy, and collaboration to help lab professionals adapt to change and provide vital insight and guidance for patient care. The organization offers accreditation programs, press releases, media advisories, and statements that spotlight scientific, clinical, and technological breakthroughs. AACC has a longstanding commitment to provide customers with the best possible experience every time they use the AACC website. Mark J. Golden has been the CEO of the American company since 2020. | Health Services |
American Society for Microbiology
American Society for Microbiology Miscellaneous Commercial ServicesCommercial Services The American Society for Microbiology (ASM) is the oldest and largest single life science membership organization in the world. The private company is based in Washington and has subsidiaries in the United States. ASM's membership has grown from 59 scientists in 1899 to more than 39,000 members today, with more than one third located outside. The members represent 26 disciplines of microbiological specialization plus a division for microbiology educators. | Commercial Services |
Association for Molecular Pathology
Association for Molecular Pathology BiotechnologyHealth Technology The Association for Molecular Pathology develops molecular diagnostics. The American company was founded by Jeffrey Cossman. | Health Technology |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Health Technology |
Inflammatix, Inc.
Inflammatix, Inc. Medical SpecialtiesHealth Technology Inflammatix, Inc. operates molecular diagnostics company which develops rapid tests that read the immune system. The firm specializes in molecular diagnostics, biotechnology, computational immunology, in-vitro diagnostics, personalized medicine and bioinformatics. The company was founded by Purvesh Khatri, Jonathan Romanowsky and Timothy Sweeney and is headquartered in Burlingame, CA. | Health Technology |